Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Case

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
American Journal of Hematology|June 1, 1987
Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosisH J Iland, J Laszlo, D C Case, et al.
Cancer|October 1, 1976
Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's diseaseD C Case, J A Hansen, E Corrales, et al.
Blood|May 1, 1977
Depressed in vitro lymphocyte responses to PHA in patients with Hodgkin disease in continuous long remissionsD C Case, J A Hansen, E Corrales, et al.
Leukemia|April 1, 1997
A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemiaE J Feldman, K Seiter, L Damon, et al.
Oncology|January 1, 1985
Combination chemotherapy for multiple myeloma with BCNU, cyclophosphamide, vincristine, melphalan, and prednisone (M-2 protocol)D C Case, H L Sonneborn, S D Paul, et al.
Cancer|March 15, 1993
Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I-II studyB R Greenberg, R D Reynolds, C B Charron, et al.
Leukemia & Lymphoma|January 1, 1993
Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphomaD C Case, M C Gerber, R A Gams, et al.
Cancer Research|July 25, 1992
Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphomaD C Case, M C Gerber, R A Gams, et al.
Cancer Treatment Reports|November 1, 1986
Phase II study of rDNA alpha-2 interferon (INTRON A) in patients with multiple myeloma utilizing an escalating induction phaseD C Case, H L Sonneborn, S D Paul, et al.
Cancer Treatment Reports|April 1, 1986
Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trialM R Cooper, A Fefer, J Thompson, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
American Journal of Hematology|June 1, 1987
Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosisH J Iland, J Laszlo, D C Case, et al.
Cancer|October 1, 1976
Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's diseaseD C Case, J A Hansen, E Corrales, et al.
Blood|May 1, 1977
Depressed in vitro lymphocyte responses to PHA in patients with Hodgkin disease in continuous long remissionsD C Case, J A Hansen, E Corrales, et al.
Leukemia|April 1, 1997
A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemiaE J Feldman, K Seiter, L Damon, et al.
Oncology|January 1, 1985
Combination chemotherapy for multiple myeloma with BCNU, cyclophosphamide, vincristine, melphalan, and prednisone (M-2 protocol)D C Case, H L Sonneborn, S D Paul, et al.
Cancer|March 15, 1993
Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I-II studyB R Greenberg, R D Reynolds, C B Charron, et al.
Leukemia & Lymphoma|January 1, 1993
Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphomaD C Case, M C Gerber, R A Gams, et al.
Cancer Research|July 25, 1992
Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphomaD C Case, M C Gerber, R A Gams, et al.
Cancer Treatment Reports|November 1, 1986
Phase II study of rDNA alpha-2 interferon (INTRON A) in patients with multiple myeloma utilizing an escalating induction phaseD C Case, H L Sonneborn, S D Paul, et al.
Cancer Treatment Reports|April 1, 1986
Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trialM R Cooper, A Fefer, J Thompson, et al.
Pageof 5